Community Fecal Carriage and Molecular Epidemiology of Extended-Spectrum β-Lactamase- and Carbapenemase-Producing Escherichia coli from Healthy Children in the Central South China

References

• Bevan ER, Jones AM, Hawkey PM. Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype. J Antimicrob Chemother. 2017;72(8):2145–2155. doi:10.1093/jac/dkx146
   PubMed Web of Science ®Google Scholar
• Bezabih YM, Sabiiti W, Alamneh E, et al. The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community. J Antimicrob Chemother. 2021;76(1):22–29. doi:10.1093/jac/dkaa399
   Web of Science ®Google Scholar
• Birgy A, Cohen R, Levy C, et al. Community faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceaein French children. BMC Infect Dis. 2012;12(1):315. doi:10.1186/1471-2334-12-315
   Web of Science ®Google Scholar
• Karanika S, Karantanos T, Arvanitis M, et al. Fecal colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae and risk factors among healthy individuals: a systematic review and metaanalysis. Clin Infect Dis. 2016;63(3):310–318. doi:10.1093/cid/ciw283
   PubMed Web of Science ®Google Scholar
• Verschuuren TD, Van Hout D, Arredondo-Alonso S, et al. Comparative genomics of ESBL-producing Escherichia coli (ESBL-Ec) reveals a similar distribution of the 10 most prevalent ESBL-Ec clones and ESBL genes among human community faecal and extra-intestinal infection isolates in the Netherlands (2014–17). J Antimicrob Chemother. 2021;76(4):901–908. doi:10.1093/jac/dkaa534
   Web of Science ®Google Scholar
• Bi Z, Berglund B, Sun Q, et al. Prevalence of the mcr-1 colistin resistance gene in extended-spectrum β-lactamase-producing Escherichia coli from human faecal samples collected in 2012 in rural villages in Shandong Province, China. Int J Antimicrob Agents. 2017;49(4):493–497. doi:10.1016/j.ijantimicag.2016.12.018
   PubMed Web of Science ®Google Scholar
• Pallecchi L, Malossi M, Mantella A, et al. Detection of CTX-M-type beta-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru. Antimicrob Agents Chemother. 2004;48(12):4556–4561. doi:10.1128/AAC.48.12.4556-4561.2004
   PubMed Web of Science ®Google Scholar
• Woerther PL, Burdet C, Chachaty E, et al. Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev. 2013;26(4):744–758. doi:10.1128/CMR.00023-13
   PubMed Web of Science ®Google Scholar
• Shafiq M, Huang J, Shah JM, et al. Characterization and resistant determinants linked to mobile elements of ESBL-producing and mcr-1-positive Escherichia coli recovered from the chicken origin. Microb Pathog. 2021;150:104722. doi:10.1016/j.micpath.2020.104722
   Web of Science ®Google Scholar
• Abdallah HM, Alnaiemi N, Reuland EA, et al. Fecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae in Egyptian patients with community-onset gastrointestinal complaints: a hospital -based cross-sectional study. Antimicrob Resist Infect Control. 2017;6(1):62. doi:10.1186/s13756-017-0219-7
   Web of Science ®Google Scholar
• Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014;27(3):543–574. doi:10.1128/CMR.00125-13
   PubMed Web of Science ®Google Scholar
• Peirano G, Pitout JDD. Extended-spectrum β-lactamase-producing Enterobacteriaceae: update on molecular epidemiology and treatment options. Drugs. 2019;79(14):1529–1541. doi:10.1007/s40265-019-01180-3
   PubMed Web of Science ®Google Scholar
• Farra A, Frank T, Tondeur L, et al. High rate of faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in healthy children in Bangui, Central African Republic. Clin Microbiol Infect. 2016;22(10):891.e1–891.e4. doi:10.1016/j.cmi.2016.07.001
   Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Ninth Informational Supplement M100-S29. Wayne, PA, USA: CLSI; 2019.
   Google Scholar
• Hijazi SM, Fawzi MA, Ali FM, et al. Prevalence and characterization of extended-spectrum beta-lactamases producing Enterobacteriaceae in healthy children and associated risk factors. Ann Clin Microbiol Antimicrob. 2016;15(1):3. doi:10.1186/s12941-016-0121-9
   Web of Science ®Google Scholar
• Li B, Lu Y, Lan F, et al. Prevalence and characteristics of ST131 clone among unselected clinical Escherichia coli in a Chinese university hospital. Antimicrob Resist Infect Control. 2017;6(1):118. doi:10.1186/s13756-017-0274-0
   Web of Science ®Google Scholar
• Subramanya SH, Bairy I, Metok Y, et al. Detection and characterization of ESBL-producing Enterobacteriaceae from the gut of subsistence farmers, their livestock, and the surrounding environment in rural Nepal. Sci Rep. 2021;11(1):2091. doi:10.1038/s41598-021-81315-3
   Web of Science ®Google Scholar
• Robicsek A, Strahilevitz J, Sahm DF, et al. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother. 2006;50(8):2872–2874. doi:10.1128/AAC.01647-05
   PubMed Web of Science ®Google Scholar
• Zhong YM, Liu WE, Zheng ZF. Epidemiology and molecular characterization of mcr-1 in Escherichia coli recovered from patients with bloodstream infections in Changsha, central China. Infect Drug Resist. 2019;12:2069–2076. doi:10.2147/IDR.S209877
   Web of Science ®Google Scholar
• Pan F, Tian D, Wang B, et al. Fecal carriage and molecular epidemiology of carbapenem-resistant Enterobacteriaceae from outpatient children in Shanghai. BMC Infect Dis. 2019;19(1):678. doi:10.1186/s12879-019-4298-3
   Web of Science ®Google Scholar
• Clermont O, Christenson JK, Denamur E, et al. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep. 2013;5(1):58–65. doi:10.1111/1758-2229.12019
   PubMed Web of Science ®Google Scholar
• Johnson JR, Clermont O, Johnston B, et al. Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. J Clin Microbiol. 2014;52(5):1358–1365. doi:10.1128/JCM.03502-13
   Web of Science ®Google Scholar
• Li S, Duan X, Peng Y, et al. Molecular characteristics of carbapenem-resistant Acinetobacter spp. from clinical infection samples and fecal survey samples in Southern China. BMC Infect Dis. 2019;19(1):900. doi:10.1186/s12879-019-4423-3
   PubMed Web of Science ®Google Scholar
• Huang IF, Lee WY, Wang JL, et al. Fecal carriage of multidrug-resistant Escherichia coli by community children in southern Taiwan. BMC Gastroenterol. 2018;18(1):86. doi:10.1186/s12876-018-0807-x
   Web of Science ®Google Scholar
• Van Den Bunt G, Liakopoulos A, Mevius DJ, et al. ESBL/AmpC-producing Enterobacteriaceae in households with children of preschool age: prevalence, risk factors and co-carriage. J Antimicrob Chemother. 2017;72(2):589–595. doi:10.1093/jac/dkw443
   Web of Science ®Google Scholar
• Birgy A, Levy C, Bidet P, et al. ESBL-producing Escherichia coli ST131 versus non-ST131: evolution and risk factors of carriage among French children in the community between 2010 and 2015. J Antimicrob Chemother. 2016;71(10):2949–2956. doi:10.1093/jac/dkw219
   Web of Science ®Google Scholar
• Colmenarejo C, Hernández-García M, Muñoz-Rodríguez JR, et al. Prevalence and risks factors associated with ESBL-producing faecal carriage in a single long-term-care facility in Spain: emergence of CTX-M-24- and CTX-M-27-producing Escherichia coli ST131-H30R. J Antimicrob Chemother. 2020;75(9):2480–2484. doi:10.1093/jac/dkaa219
   Web of Science ®Google Scholar
• Van Aartsen JJ, Moore CE, Parry CM, et al. Epidemiology of paediatric gastrointestinal colonisation by extended spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates in north-west Cambodia. BMC Microbiol. 2019;19(1):59. doi:10.1186/s12866-019-1431-9
   PubMed Web of Science ®Google Scholar
• Saleem AF, Allana A, Hale L, et al. The gut of healthy infants in the community as a reservoir of ESBL and carbapenemase-producing bacteria. Antibiotics. 2020;9(6):286. doi:10.3390/antibiotics9060286
   Web of Science ®Google Scholar
• Wang L, Yang YH, Lu Q, et al. Prevalence of extended-spectrum beta-lactamase producing Escherichia coli in pediatric patients in China. Zhonghua Yi Xue Za Zhi. 2008;88(20):1372–1375. Chinese.
   Google Scholar
• Babu R, Kumar A, Karim S, et al. Faecal carriage rate of extended-spectrum β-lactamase-producing Enterobacteriaceae in hospitalised patients and healthy asymptomatic individuals coming for health check-up. J Glob Antimicrob Resist. 2016;6:150–153. doi:10.1016/j.jgar.2016.05.007
   Web of Science ®Google Scholar
• Xu Q, Pan F, Sun Y, et al. Fecal carriage and molecular epidemiology of carbapenem-resistant Enterobacteriaceae from inpatient children in a pediatric hospital of Shanghai. Infect Drug Resist. 2020;13:4405–4415. doi:10.2147/IDR.S275549
   Web of Science ®Google Scholar
• Liu W, Chen L, Li H, et al. Novel CTX-M β–lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, Southern China. J Antimicrob Chemother. 2009;63(5):895–900. doi:10.1093/jac/dkp068
   Web of Science ®Google Scholar
• Zhong YM, Liu WE, Liang XH, et al. Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China. J Antimicrob Chemother. 2015;70(8):2223–2227. doi:10.1093/jac/dkv114
   Web of Science ®Google Scholar
• Xue G, Li J, Feng Y, et al. High prevalence of plasmid-mediated quinolone resistance determinants in Escherichia coli and Klebsiella pneumoniae isolates from pediatric patients in China. Microb Drug Resist. 2017;23(1):107–114. doi:10.1089/mdr.2016.0004
   PubMed Web of Science ®Google Scholar
• Chiotos K, Tamma PD, Flett KB, et al. Increased 30-day mortality associated with carbapenem-resistant Enterobacteriaceae in children. Open Forum Infect Dis. 2018;5(10):ofy222. doi:10.1093/ofid/ofy222
   PubMed Web of Science ®Google Scholar
• Chiotos K, Hayes M, Gerber JS, et al. Treatment of carbapenem-resistant Enterobacteriaceae infections in children. J Pediatric Infect Dis Soc. 2020;9(1):56–66. doi:10.1093/jpids/piz085
   PubMed Web of Science ®Google Scholar
• Ding Y, Wang Y, Hsia Y, et al. Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China. Ann Clin Microbiol Antimicrob. 2019;18(1):36. doi:10.1186/s12941-019-0334-9
   PubMed Web of Science ®Google Scholar
• Giani T, Sennati S, Antonelli A, et al. High prevalence of carriage of mcr-1-positive enteric bacteria among healthy children from rural communities in the Chaco region, Bolivia, September to October 2016. Euro Surveill. 2018;23(45):1800115. doi:10.2807/1560-7917.ES.2018.23.45.1800115
   Google Scholar
• Hassan J, Mann D, Li S, et al. Emergence of the mobile colistin resistance gene, mcr-1, in multidrug-resistant E. coli isolated from the fecal matter of toddlers in a community. Antimicrob Agents Chemother. 2021;65(5):e00243–21. doi:10.1128/AAC.00243-21
   Web of Science ®Google Scholar
• Hu YY, Wang YL, Sun QL, et al. Colistin resistance gene mcr-1 in gut flora of children. Int J Antimicrob Agents. 2017;50(4):593–597. doi:10.1016/j.ijantimicag.2017.06.011
   PubMed Web of Science ®Google Scholar
• Zhang XF, Doi Y, Huang X, et al. Possible transmission of mcr-1-harboring Escherichia coli between companion animals and human. Emerg Infect Dis. 2016;22(9):1679–1681. doi:10.3201/eid2209.160464
   PubMed Web of Science ®Google Scholar
• Yair Y, Gophna U. Pandemic bacteremic Escherichia Coli strains: evolution and emergence of drug-resistant pathogens. Curr Top Microbiol Immunol. 2018;416:163–180. doi:10.1007/82_2018_109
   Web of Science ®Google Scholar
• Muller A, Gbaguidi-Haore H, Cholley P, et al. Hospital-diagnosed infections with Escherichia coli clonal group ST131 are mostly acquired in the community. Sci Rep. 2021;11(1):5702. doi:10.1038/s41598-021-85116-6
   Web of Science ®Google Scholar
• Mohamed M, Clabots C, Porter SB, et al. Large fecal reservoir of Escherichia coli sequence type 131-H30 subclone strains that are shared within households and resemble clinical st131-H30 isolates. J Infect Dis. 2020;221(10):1659–1668. doi:10.1093/infdis/jiz669
   Web of Science ®Google Scholar
• Yoon EJ, Choi MH, Park YS, et al. Impact of host-pathogen-treatment tripartite components on early mortality of patients with Escherichia coli bloodstream infection: prospective observational study. EBioMedicine. 2018;35:76–86. doi:10.1016/j.ebiom.2018.08.029
   PubMed Web of Science ®Google Scholar
• Ferjani S, Saidani M, Maamar E, et al. coli colonizing healthy children in Tunisia: high prevalence of extra-intestinal pathovar and occurrence of non-extended-spectrum-β-lactamase-producing ST131 clone. Int J Antimicrob Agents. 2018;52(6):878–885. doi:10.1016/j.ijantimicag.2018.07.015
   Web of Science ®Google Scholar
• Barrios-Villa E, Cortés-Cortés G. Lozano-Zaraín et al.Adherent/invasive Escherichia coli (AIEC) isolates from asymptomatic people: new E. coli ST131 O25: H4/H30-Rxvirotypes. Ann Clin Microbiol Antimicrob. 2018;17(1):42. doi:10.1186/s12941-018-0295-4
   Web of Science ®Google Scholar
• Zhang S, Zhang Q, Huang J, et al. Epidemic potential of Escherichia coli O16: H41-ST131:compared with pandemic O25b: H30-ST131Lineage. Infect Drug Resist. 2021;14:2625–2632. doi:10.2147/IDR.S313261
   Web of Science ®Google Scholar
• Harris PNA, Ben Zakour NL, Roberts LW, et al. Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27. J Antimicrob Chemother. 2018;73(3):634–642. doi:10.1093/jac/dkx466
   Web of Science ®Google Scholar
• Birgy A, Levy C, Nicolas-Chanoine MH, et al. Independent host factors and bacterial genetic determinants of the emergence and dominance of Escherichia coli Sequence type 131 CTX-M-27 in a community pediatric cohort study. Antimicrob Agents Chemother. 2019;63(7):e00382–19. doi:10.1128/AAC.00382-19
   PubMed Web of Science ®Google Scholar
• Adler A, Gniadkowski M, Baraniak A, et al. Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre. Clin Microbiol Infect. 2012;18(12):E497–505. doi:10.1111/j.1469-0691.2012.03999.x
   Web of Science ®Google Scholar
• Peirano G, Lynch T, Matsumara Y, et al. Trends in population dynamics of Escherichia coli sequence type 131, Calgary, Alberta, Canada, 2006–2016 (1). Emerg Infect Dis. 2020;26(12):2907–2915. doi:10.3201/eid2612.201221
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Pitout JD, Gomi R, et al. Global Escherichia coli sequence type 131 clade with bla (CTX-M-27) Gene. Emerg Infect Dis. 2016;22(11):1900–1907. doi:10.3201/eid2211.160519
   PubMed Web of Science ®Google Scholar
• Platell JL, Trott DJ, Johnson JR, et al. Prominence of an O75 clonal group (clonal complex 14) among non-ST131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia. Antimicrob Agents Chemother. 2012;56(7):3898–3904. doi:10.1128/AAC.06120-11
   PubMed Web of Science ®Google Scholar
• Birgy A, Madhi F, Jung C, et al. Diversity and trends in population structure of ESBL-producing Enterobacteriaceae in febrile urinary tract infections in children in France from 2014 to 2017. J Antimicrob Chemother. 2020;75(1):96–105. doi:10.1093/jac/dkz423
   PubMed Web of Science ®Google Scholar
• Ding Y, Zhang J, Yao K, et al. Molecular characteristics of the new emerging global clone ST1193 among clinical isolates of Escherichia coli from neonatal invasive infections in China. Eur J Clin Microbiol Infect Dis. 2021;40(4):833–840. doi:10.1007/s10096-020-04079-0
   Web of Science ®Google Scholar